SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52153 679 3 CRSP
Emcee:  Biomaven Type:  Moderated
Min  Hr  Day  Wk  Mon  Yr  3 Yr  Log
Introduction Market Data Compact
CRSP 50.92-2.5%3:27 PM EST
Top Headlines - Crispr Therapeutics AG
Human Gene Editing and the CRISPR Revolution 50 minutes ago
Advyzon Investment Management LLC Invests $282,000 in CRISPR Therapeutics AG $CRSP 10 AM
Robert W. Baird Issues Pessimistic Forecast for CRISPR Therapeutics (NASDAQ:CRSP) Stock Price 8 AM
Brookline Capital Management Estimates CRSP Q4 Earnings 7 AM
Needham & Company LLC Issues Pessimistic Forecast for CRISPR Therapeutics (NASDAQ:CRSP) Stock Price yesterday
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
52153Congrats to REGN on FOP investor.regeneron.comJamesK-September 17
52152…. And one last comment from me With no AI assistant help. Even if these failIan@SI-August 5
52151Here’s a quick response from Gemini to my first question on Tau tangle research.Ian@SI-August 5
52150I also asked Gemini how rapid the researchers were migrating to different approaIan@SI1August 5
52149Art, I’ve updated my data as it was a month or two old. I had misunderstood thIan@SI-August 5
52148It's one thing to believe tau causes Alzheimer's and another thing altogArt Bechhoefer-August 5
52147to believe that Tau causes Alzheimer’s disease, you have to believe that a few mIan@SI-August 5
52146Alan, An increasing number of researchers, now believe that amyloid, beta and taIan@SI-August 5
52145I was in too much of a hurry. Vertex has cancelled their follow-on to Journavx, A.J. Mullen1August 5
52144Vertex cancels its non-opioid pain-reliever, barrons.com. That's bad news foA.J. Mullen-August 5
52143Both ARGX and ALNY had blow out earnings today. Doesn't seem to help the indJamesK1July 31
52142IBRX is up more than 50% over the last 30 days and still 50% below it's 52 wAloner2June 6
52141I understand. We could both post media stories. As a biotech investor I'm waJamesK-April 18
52140At any given time, there are likely to be a few small biotech companies who haveDewDiligence_on_SI-April 18
52139I have no inside information. Drug development is slowing down after FDA cuts. JamesK-April 18
52138investorshub.advfn.comDewDiligence_on_SI-April 14
52137The FDA recently terminated 800 employees responsible for approving new drug appArt Bechhoefer1April 14
52136The Breakthrough Blood Test for Alzheimer's Disease: The p-Tau217 Biomarkersoftware salesperson1April 14
52135hmmm, IGMS has about $183 million cash at last report but as far as I can tell tJamesK-April 12
52134BIIB selling for less than 2 times sales. SRPT selling for about 2.5 times salesJamesK-April 12
52133More on the same subject: investorshub.advfn.comDewDiligence_on_SI-March 21
52132Message 35074195 The FDA is still working despite the firings. It approved an exA.J. Mullen2March 21
52131of interest to those who have or are considering uhc's medicare advantage plsoftware salesperson412/30/2024
52130Mark Cuban’s interview with Eric Topol A far-reaching discussion on how Cuban asoftware salesperson-12/23/2024
52129Healthcare musings I’ll present a few articles i have been reading and then dissoftware salesperson112/13/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News